메뉴 건너뛰기




Volumn 58, Issue 12, 2010, Pages 2434-2435

Albumin: Creatinine ratio predicts mortality after stroke: Analysis of the third national health and nutrition examination survey

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C;

EID: 78650138722     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03158.x     Document Type: Letter
Times cited : (6)

References (8)
  • 1
    • 0031717877 scopus 로고    scopus 로고
    • Microalbuminuria and coronary heart disease in NIDDM: An incidence study
    • Mattock MB, Barnes DJ, Viberti G, et al,. Microalbuminuria and coronary heart disease in NIDDM: An incidence study. Diabetes 1998; 47: 1786.
    • (1998) Diabetes , vol.47 , pp. 1786
    • Mattock, M.B.1    Barnes, D.J.2    Viberti, G.3
  • 2
    • 0029760174 scopus 로고    scopus 로고
    • Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men
    • Ljungman S, Wikstrand J, Hartford M, et al,. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770.
    • (1996) Am J Hypertens , vol.9 , pp. 770
    • Ljungman, S.1    Wikstrand, J.2    Hartford, M.3
  • 3
    • 33747445884 scopus 로고    scopus 로고
    • Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases
    • Klausen KP, Scharling H, Jensen JS., Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 2006; 260: 231-237.
    • (2006) J Intern Med , vol.260 , pp. 231-237
    • Klausen, K.P.1    Scharling, H.2    Jensen, J.S.3
  • 4
    • 0029591664 scopus 로고
    • Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals
    • Jensen JS., Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chem Acta 1995; 243: 95-99.
    • (1995) Clin Chem Acta , vol.243 , pp. 95-99
    • Jensen, J.S.1
  • 5
    • 0030780566 scopus 로고    scopus 로고
    • Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality
    • Berton G, Citro T, Palmieri R, et al,. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997; 96: 3338-3345.
    • (1997) Circulation , vol.96 , pp. 3338-3345
    • Berton, G.1    Citro, T.2    Palmieri, R.3
  • 6
    • 27744482031 scopus 로고    scopus 로고
    • Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans
    • Strain WD, Chaturvedi N, Nihoyannopoulos P, et al,. Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans. Diabetologia 2005; 48: 2269-2277.
    • (2005) Diabetologia , vol.48 , pp. 2269-2277
    • Strain, W.D.1    Chaturvedi, N.2    Nihoyannopoulos, P.3
  • 7
    • 34547615709 scopus 로고    scopus 로고
    • Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G, De Backer G, Dominiczak A, et al,. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
    • (2007) Eur Heart J , vol.28 , pp. 1462-1536
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3
  • 8
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981.
    • (2002) JAMA , vol.288 , pp. 2981


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.